Unknown PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT04382157

Magnesium Replacement and Hyperglycemia After Kidney Transplantation

Sponsor: Oslo University Hospital

Conditions Hypomagnesemia Kidney Transplantation

Updated 6 times since 2020 Last updated: Sep 27, 2021 Started: Feb 25, 2020 Primary completion: Aug 31, 2022 Completion: Aug 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Hypomagnesemia and Kidney Transplantation and is currently ongoing. Oslo University Hospital leads this study, which shows 6 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1/PHASE2

Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Oct 2023 — Jul 2024 [monthly]

Unknown Status PHASE1_PHASE2

Status: Recruiting → Unknown Status
Oct 2021 — Oct 2023 [monthly]

Recruiting PHASE1_PHASE2
Jan 2021 — Oct 2021 [monthly]

Recruiting PHASE1_PHASE2

▶ Show 1 earlier version

Jun 2020 — Jan 2021 [monthly]

Recruiting PHASE1_PHASE2

First recorded

Feb 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Oslo University Hospital

Data source: Oslo University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Oslo, Norway